All Updates

Gov. Brad Little has proclaimed Monday Cancer Action Day in Idaho as dozens of patients, survivors and advocates traveled from all parts of the Gem State to ask lawmakers to prioritize cancer in their policies, specifically making sure health care is affordable and accessible.

The American Cancer Society Cancer Action Network (ACS CAN) brought advocates to the Statehouse Monday for the annual “Suits and Sneakers” Cancer Action Day. Cancer patients, survivors and their families and caregivers asked lawmakers to wear their suits and sneakers and to “get active” in making cancer a policy priority.

HARTFORD, CT – This year, in Connecticut, 23,550 people will hear the words, “You have cancer,” and 6,440 will lose their lives to cancer. Yesterday, Gov. Ned Lamont gave his annual state budget address, proposing slashing funding to life-saving cancer prevention and control programs, including suspension of tobacco control

LANSING, MICH. – Today, Gov. Gretchen Whitmer introduced her proposed budget, which increases funding for programs addressing tobacco use in the state. The following is a statement from Molly Medenblik, government relations director for the American Cancer Society Cancer Action Network (ACS CAN) in Michigan: "Tobacco use remains

HARRISBURG, PA – FEBRUARY 7, 2024 – The American Cancer Society Cancer Action Network (ACS CAN) joins patient advocates and public health organizations across the state in applauding Governor Shapiro’s proposed 2024-25 Executive Budget, which outlines a $4 million investment to wipe out as much as $400 million in Pennsylvanians’

INDIANAPOLIS, IN – This afternoon, the Indiana Senate passed Senate Bill 273, which would ensure biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments, is covered by more insurance plans in the Hoosier state. The following is a statement from

Today, the American Cancer Society Cancer Action Network (ACS CAN) issued a letter to the National Institutes of Standards and Technology (NIST) commenting on the utilization of march-in rights (MIR) to lower prescription drug costs following the release of new guidance by the administration on its application.